Provided by Tiger Trade Technology Pte. Ltd.

Agree

72.25
-0.6830-0.94%
Volume:1.23M
Turnover:89.34M
Market Cap:8.99B
PE:39.02
High:73.15
Open:73.00
Low:72.21
Close:72.93
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.30
T/O Rate:1.01%
Dividend:3.14
Dividend Rate:4.35%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.42
PE(LYR):40.82

Loading ...

BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms

GlobeNewswire
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

GlobeNewswire
·
Jul 28

Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data

TIPRANKS
·
Jul 28

South Korea, Brazil Agree to Accelerate Mercosur Trade Deal Talks

MT Newswires Live
·
Jul 28

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

TIPRANKS
·
Jul 28

Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

TIPRANKS
·
Jul 27

Kelun Pharmaceutical's Subsidiary Kelun-Biotech Gets Approval for Clinical Trial of Novel Dual-Load ADC Drug SKB565

Stock News
·
Jul 27

Impact Therapeutics Nominates Preclinical Candidate for GI Cancers

MT Newswires Live
·
Jul 27

IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201

TIPRANKS
·
Jul 27

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Simply Wall St.
·
Jul 26

BIOKIN's T-Bren (HER2 ADC) Trial Enrolls First Subject in Phase III Study

Stock News
·
Jul 26

West Java's Street Crime Bounty Plan: Does the Minister Agree?

Tempo
·
Jul 24

Press Release: Samsung Epis Holdings Reports Second Quarter and Half-year 2026 Financial Results

Dow Jones
·
Jul 24

Sichuan Biokin Pharmaceutical's ADC Enters Phase Three Trial for Biliary Tract Cancer

MT Newswires Live
·
Jul 24

Earning Preview: Agree Realty revenue is expected to increase by 18.08%, and institutional views are bullish

Earnings Agent
·
Jul 24

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

GlobeNewswire
·
Jul 24

Agree Realty (ADC) Stock Looks Fully Valued With Strong Returns But Rich Earnings

Simply Wall St.
·
Jul 24

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity

GlobeNewswire
·
Jul 22

Agree Realty is Maintained at Equal-weight by Barclays

Dow Jones
·
Jul 22

Agree Realty price target raised to $85 from $84 at Barclays

TIPRANKS
·
Jul 22